Gene Therapy for Rare Disorders Summit

Date: 30-Apr-18 to 02-May-18
Location: Sheraton Boston Hotel / Boston / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

2018 is set to be a landmark year for the gene therapy field. After decades of unfulfilled potential, this space is gaining tangible momentum, particularly in addressing the significant unmet need in a range of rare diseases.

Gene Therapy for Rare Disorders 2018 will equip you with the insights to make the most of this unprecedented opportunity. Rather than attempting to cover the entire cell and gene therapy world, this meeting will focus specifically on the critical clinical, manufacturing, regulatory and reimbursement challenges involved in delivering gene therapies to market.

Leaders from the likes of Spark, Pfizer, GSK and Bluebird Bio will deliver in-depth insights into the work that has underpinned their success, enabling you to maximize the commercial potential of your gene therapy products.

Join your colleagues at this uniquely focused event to ensure you’re making the right decisions with your gene therapy pipeline at such a pivotal time for the field.

Early booking discounts are available in addition to group rates. For more information, visit the website: http://bit.ly/2kPOU15

Exhibitors

Katherine High (Spark Therapeutics), Philip Gregory (Bluebird Bio), Steven Paul (Voyager Therapeutics), Jude Samulski (Pfizer), Steven Zelenkofske (uniQure), Mary Dunkle (NORD)

Go to event website